ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1910

ERAP1 Deficiency Implicates Long Peptides in Protection from HLA-B27-Induced Experimental Spondyloarthritis

Tri Tran1, Tejpal Gill1, Joshua R. Bennett1, Vance Holt1, Sohee Hong2, Joel Taurog3 and Robert Colbert1, 1National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, 2National Institutes of Arthritis and Muskuloskeletal and skin diseases, National Institutes of Health, Bethesda, MD, 3Dept Int Med-Rheum Dis Div, University of Texas Southwestern Medical Center, Dallas, TX

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Animal models, ER Stress, human leukocyte antigens (HLA) and spondylarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 6, 2017

Title: Spondyloarthropathies and Psoriatic Arthritis – Pathogenesis, Etiology

Session Type: ACR Concurrent Abstract Session

Session Time: 4:30PM-6:00PM

Background/Purpose: Common endoplasmic reticulum (ER) aminopeptidase 1 (ERAP1) haplotypes influence the risk of developing axial spondyloarthritis (SpA) in HLA-B27-positive individuals, with loss-of-function and reduced expression conferring protection. ERAP1 increases the pool of short peptides, which are thought to be optimal for binding to most HLA class I molecules. The role of B27 in this model is not clearly defined, although misfolding and expression of cell surface dimers have both been implicated, while CD8+ T cells appear to be dispensible. Thus, the role of peptides in axial SpA remains unclear. We investigated the interaction between ERAP1 and HLA-B27 in the rat model of SpA.

Methods: ERAP1-deficient rats generated by genome editing were crossed with disease prone HLA-B27 transgenic (B27 Tg) rats (33-3 Tg locus), and B7 Tg rats as controls. The phenotype was monitored for up to 6 months. Colitis was assessed by stool and histology scores. Bone marrow-derived macrophages (BMM) were used to examine HLA class I by FACS and immunoprecipitation with conformation-specific antibodies. ER stress was assessed by quantitative PCR.

Results: ERAP1 deficiency reduced the prevalence of arthritis and orchitis by 64% and 58%, respectively (p<0.05), in male B27 Tg rats. Clinical colitis was unaffected, while histology scores were slightly increased in rats lacking ERAP1 (p<0.05). Wild type and B7 Tg rats with and without ERAP1 remained healthy. BMM from B27 Tg ERAP1-/- rats exhibited a 12-fold increase in cell surface B27 displaying long peptides (MARB4), a 40% and 50% increase in free heavy chains (FHC) and FHC dimers of B27, respectively (p<0.05), while folded complexes (ME1) were increased 25% (NS). Immunoprecipitation of total cellular folded and FHC revealed that ERAP1 deficiency reduced the pool of B27 FHC by 30%, including a 50% reduction in misfolded disulfide-linked and BiP-bound dimers, and increased the ratio of folded/free HC by 56% (p<0.05 for each). In contrast, for B7, total cellular FHC were increased 3-fold (p<0.05) by ERAP1 deficiency, and the ratio of folded/free HC was reduced by 60% (p<0.05). B27 upregulation results in the accumulation of misfolded, disulfide-linked dimers. ERAP1-deficiency resulted in a significant reduction in the accumulation of misfolded and BiP-bound B27 during upregulation. This was associated with attenuated activation of the unfolded protein response, with upregulation of Hsp5a and Ddit3 reduced by up to 50%, and attenuated Xbp1 splicing (p<0.05).

Conclusion: ERAP1-deficiency protects B27 Tg line 33-3 rats from arthritis and orchitis, without reducing the severity of gut inflammation. We demonstrate that ERAP1 deficiency promotes B27 folding and reduces misfolding and its consequences, while increasing the expression of cell surface dimers and aberrant long peptide complexes. Interestingly, ERAP1 deficiency impairs the formation of folded B7 complexes, consistent with the importance of short peptides for most other HLA alleles. Together, these results suggest that the preservation of long peptides in the absence of ERAP1 may rescue B27 from misfolding, and identify ERAP1 as a potential target for therapeutic intervention in SpA.


Disclosure: T. Tran, None; T. Gill, None; J. R. Bennett, None; V. Holt, None; S. Hong, None; J. Taurog, Abbvie; Anges; Inc; Celgene, 5; R. Colbert, None.

To cite this abstract in AMA style:

Tran T, Gill T, Bennett JR, Holt V, Hong S, Taurog J, Colbert R. ERAP1 Deficiency Implicates Long Peptides in Protection from HLA-B27-Induced Experimental Spondyloarthritis [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/erap1-deficiency-implicates-long-peptides-in-protection-from-hla-b27-induced-experimental-spondyloarthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/erap1-deficiency-implicates-long-peptides-in-protection-from-hla-b27-induced-experimental-spondyloarthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology